
Clarium Secures $27M to Enhance AI Supply Chain Platform
Clarium has raised $27 million in a Series A funding round led by Northzone, with participation from existing investors such as General Catalyst, Kaiser Permanente Ventures, and others, announced in a press release. This funding brings Clarium's total investment to $43 million, enabling the company to expand its AI-powered supply chain resiliency platform, Astra OS, across leading health systems.
The platform, which integrates real-time data to predict supply chain disruptions, is designed to help hospitals manage their supply chain operations more efficiently. By automating data collection and providing tailored recommendations, Clarium aims to mitigate disruptions and optimize inventory management. Hospitals using Astra OS have reported significant cost savings and improved operational efficiency.
The new funding will support the development of additional applications and solutions within Astra OS, as well as the expansion of Clarium's team and partnerships with new health systems. The company has already collaborated with major institutions like Yale New Haven Health and Kaiser Permanente to enhance its platform's capabilities.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish like Life AI Weekly.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Avio Health Unveils Functional Medicine LLM for Personalized Healthcare
Novo Nordisk Foundation Allocates DKK 479 Million for AI and Health Projects
Infinitus Expands AI Partnership with Salesforce for Healthcare
RevelAi Health Secures $3.1 Million to Enhance AI in Musculoskeletal Care
More from: Funding
Clio to Acquire vLex for $1 Billion, Expanding AI Legal Technology
Recognize Closes $1.7 Billion Fund for Digital Services Investments
Chang Robotics Fund Deploys Initial Capital to Boost U.S. Manufacturing
Audos Secures $11.5 Million to Empower AI Entrepreneurs
Gensmo Secures $60M to Revolutionize Fashion E-Commerce with AI
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more